Cargando…

Going circular: history, present, and future of circRNAs in cancer

To date, thousands of highly abundant and conserved single-stranded RNA molecules shaped into ring structures (circRNAs) have been identified. CircRNAs are multifunctional molecules that have been shown to regulate gene expression transcriptionally and post-transcriptionally and exhibit distinct tis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisignano, Giuseppina, Michael, David C., Visal, Tanvi H., Pirlog, Radu, Ladomery, Michael, Calin, George A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504067/
https://www.ncbi.nlm.nih.gov/pubmed/37587333
http://dx.doi.org/10.1038/s41388-023-02780-w
_version_ 1785106646204153856
author Pisignano, Giuseppina
Michael, David C.
Visal, Tanvi H.
Pirlog, Radu
Ladomery, Michael
Calin, George A.
author_facet Pisignano, Giuseppina
Michael, David C.
Visal, Tanvi H.
Pirlog, Radu
Ladomery, Michael
Calin, George A.
author_sort Pisignano, Giuseppina
collection PubMed
description To date, thousands of highly abundant and conserved single-stranded RNA molecules shaped into ring structures (circRNAs) have been identified. CircRNAs are multifunctional molecules that have been shown to regulate gene expression transcriptionally and post-transcriptionally and exhibit distinct tissue- and development-specific expression patterns associated with a variety of normal and disease conditions, including cancer pathogenesis. Over the past years, due to their intrinsic stability and resistance to ribonucleases, particular attention has been drawn to their use as reliable diagnostic and prognostic biomarkers in cancer diagnosis, treatment, and prevention. However, there are some critical caveats to their utility in the clinic. Their circular shape limits their annotation and a complete functional elucidation is lacking. This makes their detection and biomedical application still challenging. Herein, we review the current knowledge of circRNA biogenesis and function, and of their involvement in tumorigenesis and potential utility in cancer-targeted therapy.
format Online
Article
Text
id pubmed-10504067
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105040672023-09-17 Going circular: history, present, and future of circRNAs in cancer Pisignano, Giuseppina Michael, David C. Visal, Tanvi H. Pirlog, Radu Ladomery, Michael Calin, George A. Oncogene Review Article To date, thousands of highly abundant and conserved single-stranded RNA molecules shaped into ring structures (circRNAs) have been identified. CircRNAs are multifunctional molecules that have been shown to regulate gene expression transcriptionally and post-transcriptionally and exhibit distinct tissue- and development-specific expression patterns associated with a variety of normal and disease conditions, including cancer pathogenesis. Over the past years, due to their intrinsic stability and resistance to ribonucleases, particular attention has been drawn to their use as reliable diagnostic and prognostic biomarkers in cancer diagnosis, treatment, and prevention. However, there are some critical caveats to their utility in the clinic. Their circular shape limits their annotation and a complete functional elucidation is lacking. This makes their detection and biomedical application still challenging. Herein, we review the current knowledge of circRNA biogenesis and function, and of their involvement in tumorigenesis and potential utility in cancer-targeted therapy. Nature Publishing Group UK 2023-08-16 2023 /pmc/articles/PMC10504067/ /pubmed/37587333 http://dx.doi.org/10.1038/s41388-023-02780-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Pisignano, Giuseppina
Michael, David C.
Visal, Tanvi H.
Pirlog, Radu
Ladomery, Michael
Calin, George A.
Going circular: history, present, and future of circRNAs in cancer
title Going circular: history, present, and future of circRNAs in cancer
title_full Going circular: history, present, and future of circRNAs in cancer
title_fullStr Going circular: history, present, and future of circRNAs in cancer
title_full_unstemmed Going circular: history, present, and future of circRNAs in cancer
title_short Going circular: history, present, and future of circRNAs in cancer
title_sort going circular: history, present, and future of circrnas in cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504067/
https://www.ncbi.nlm.nih.gov/pubmed/37587333
http://dx.doi.org/10.1038/s41388-023-02780-w
work_keys_str_mv AT pisignanogiuseppina goingcircularhistorypresentandfutureofcircrnasincancer
AT michaeldavidc goingcircularhistorypresentandfutureofcircrnasincancer
AT visaltanvih goingcircularhistorypresentandfutureofcircrnasincancer
AT pirlogradu goingcircularhistorypresentandfutureofcircrnasincancer
AT ladomerymichael goingcircularhistorypresentandfutureofcircrnasincancer
AT calingeorgea goingcircularhistorypresentandfutureofcircrnasincancer